ABG-WTT Global Life Science Capital Partners GP Ltd Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001832108

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 2 positions · Total reported value $8.55M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 50.0% · 0 new · 0 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, ABG-WTT Global Life Science Capital Partners GP Ltd disclosed 2 equity positions with a combined reported value of $8.55M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were CBLL ($5.36M), RPID ($3.20M). By sector, the heaviest allocations are Health Care 62.6%, Industrials 37.4%. Versus the prior quarter, allocation shifted toward Industrials (+3.3pp) and away from Health Care (-3.3pp).

Versus the prior quarter, ABG-WTT Global Life Science Capital Partners GP Ltd opened 0 new positions, trimmed 0 and fully exited 1, a turnover rate of 50.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest ABG-WTT Global Life Science Capital Partners GP Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

ABG-WTT Global Life Science Capital Partners GP Ltd is an SEC-registered 13F filer. As of Q3 2026 it reported 1 US equity positions with a combined value of $1.90M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 1 positions · $1.90M reported value (Q3 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: RPID (RAPID MICRO BIOSYSTEMS INC) at 100.0%
  • Average position size: $1.90M

Sector Tilt

  • Industrials 100.0%
  • (classified holdings cover 100% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to be maintaining a cautious stance, with a focus on stability rather than aggressive growth. The reduction in the position of CERIBELL INC suggests a preference for less volatile or more established companies. 2. Key Moves: - Reduction: The fund reduced its position in CERIBELL INC by 37.7% from the previous quarter, which indicates a shift away from the Health Care sector. - Hold: The fund maintained its position in RAPID MICRO BIOSYSTEMS INC, showing a preference for continuity in the Industrials sector. 3. Portfolio Structure: - Passive/Active: The portfolio seems to lean towards a passive approach, as there were no new positions added and the existing ones were only adjusted slightly. - Sector Bias: The fund has a clear bias towards the Health Care and Industrials sectors, with the largest holding in Health Care and a significant position in Industrials. - Risk Appetite: The risk appetite is moderate, as the fund did not take on any new positions and reduced its exposure to a single stock, indicating a preference for conservative management. 4. Per-Holding One-Liner: - CBLL (CERIBELL INC): A biotechnology company focused on developing therapies for neurological disorders. 'Unverified' - RPID (RAPID MICRO BIOSYSTEMS INC): A company specializing in rapid diagnostic tests for infectious diseases. 'Unverified' 5. One-Sentence Style Summary: The ABG-WTT Global Life Science Capital Partners GP Ltd fund maintained a conservative approach in Q2 2026, reducing exposure to CERIBELL INC in the Health Care sector while holding steady in the Industrials sector with RAPID MICRO BIOSYSTEMS INC.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 62.6%
Industrials 37.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 275.33K $5.36M 62.61%
62.61%
Reduce
2 1.85M $3.20M 37.39%
37.39%
Hold

FAQ

What did ABG-WTT Global Life Science Capital Partners GP Ltd buy in 2026-Q2?

In its 2026-Q2 13F filing, ABG-WTT Global Life Science Capital Partners GP Ltd reported 2 equity positions worth $8.55M in aggregate; its largest disclosed positions were CBLL ($5.36M), RPID ($3.20M).

How large is ABG-WTT Global Life Science Capital Partners GP Ltd's portfolio?

ABG-WTT Global Life Science Capital Partners GP Ltd reported $8.55M of long equity holdings across 2 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is ABG-WTT Global Life Science Capital Partners GP Ltd's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/abg-wtt-global-life-science-capital-partners-gp/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →